Correlation Between Genmab AS and Formuepleje Limittellus

Can any of the company-specific risk be diversified away by investing in both Genmab AS and Formuepleje Limittellus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Formuepleje Limittellus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genmab AS and Formuepleje Limittellus, you can compare the effects of market volatilities on Genmab AS and Formuepleje Limittellus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Formuepleje Limittellus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Formuepleje Limittellus.

Diversification Opportunities for Genmab AS and Formuepleje Limittellus

-0.37

Correlation Coefficient

Genmab AS  Formuepleje Limittellus

Very good diversification

The 3 months correlation between Genmab and Formuepleje is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Formuepleje Limittellus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Formuepleje Limittellus and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Formuepleje Limittellus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Formuepleje Limittellus has no effect on the direction of Genmab AS i.e., Genmab AS and Formuepleje Limittellus go up and down completely randomly.

Pair Corralation between Genmab AS and Formuepleje Limittellus

Assuming the 90 days trading horizon Genmab AS is expected to generate 3.26 times more return on investment than Formuepleje Limittellus. However, Genmab AS is 3.26 times more volatile than Formuepleje Limittellus. It trades about 0.27 of its potential returns per unit of risk. Formuepleje Limittellus is currently generating about -0.28 per unit of risk. If you would invest  142,450  in Genmab AS on December 2, 2024 and sell it today you would earn a total of  18,400  from holding Genmab AS or generate 12.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genmab AS  vs.  Formuepleje Limittellus

Genmab AS

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Formuepleje Limittellus

Risk-Adjusted Performance

Very Weak

Over the last 90 days Formuepleje Limittellus has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Formuepleje Limittellus is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Genmab AS and Formuepleje Limittellus

The main advantage of trading using opposite Genmab AS and Formuepleje Limittellus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Formuepleje Limittellus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Formuepleje Limittellus will offset losses from the drop in Formuepleje Limittellus' long position.

The idea behind Genmab AS and Formuepleje Limittellus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.